• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液神经丝轻链是衰老和白质损伤的标志物。

Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage.

机构信息

Department of Neurology, School of Medicine, Washington University in St. Louis, St. Louis, MO, USA.

Department of Neurology, School of Medicine, Washington University in St. Louis, St. Louis, MO, USA.

出版信息

Neurobiol Dis. 2022 May;166:105662. doi: 10.1016/j.nbd.2022.105662. Epub 2022 Feb 12.

DOI:10.1016/j.nbd.2022.105662
PMID:35167933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9112943/
Abstract

BACKGROUND

Cerebrospinal fluid (CSF) neurofilament light chain (NfL) reflects neuro-axonal damage and is increasingly used to evaluate disease progression across neurological conditions including Alzheimer disease (AD). However, it is unknown how NfL relates to specific types of brain tissue. We sought to determine whether CSF NfL is more strongly associated with total gray matter, white matter, or white matter hyperintensity (WMH) volume, and to quantify the relative importance of brain tissue volume, age, and AD marker status (i.e., APOE genotype, brain amyloidosis, tauopathy, and cognitive status) in predicting CSF NfL.

METHODS

419 participants (Clinical Dementia Rating [CDR] Scale > 0, N = 71) had CSF, magnetic resonance imaging (MRI), and neuropsychological data. A subset had amyloid positron emission tomography (PET) and tau PET. Pearson correlation analysis was used to determine the association between CSF NfL and age. Multiple regression was used to determine which brain volume (i.e., gray, white, or WMH volume) most strongly associated with CSF NfL. Stepwise regression and dominance analyses were used to determine the individual contributions and relative importance of brain volume, age, and AD marker status in predicting CSF NfL.

RESULTS

CSF NfL increased with age (r = 0.59, p < 0.001). Elevated CSF NfL was associated with greater total WMH volume (p < 0.001), but not gray or white matter volume (p's > 0.05) when considered simultaneously. Age and WMH volume were consistently more important (i.e., have greater R values) than AD markers when predicting CSF NfL.

CONCLUSIONS

CSF NfL is a non-specific marker of aging and white matter integrity with limited sensitivity to specific markers of AD. CSF NfL likely reflects processes associated with cerebrovascular disease.

摘要

背景

脑脊液(CSF)神经丝轻链(NfL)反映神经轴突损伤,越来越多地用于评估包括阿尔茨海默病(AD)在内的各种神经疾病的疾病进展。然而,目前尚不清楚 NfL 与特定类型的脑组织之间的关系。我们旨在确定 CSF NfL 是否与总灰质、白质或白质高信号(WMH)体积的相关性更强,并定量分析脑体积、年龄和 AD 标志物状态(即 APOE 基因型、脑淀粉样变性、tau 病和认知状态)在预测 CSF NfL 中的相对重要性。

方法

419 名参与者(临床痴呆评定量表[CDR]评分>0,N=71)接受了 CSF、磁共振成像(MRI)和神经心理学数据检测。部分参与者接受了淀粉样蛋白正电子发射断层扫描(PET)和 tau PET 检测。采用 Pearson 相关分析确定 CSF NfL 与年龄之间的相关性。采用多元回归分析确定与 CSF NfL 相关性最强的脑容量(即灰质、白质或 WMH 体积)。采用逐步回归和优势分析确定脑体积、年龄和 AD 标志物状态在预测 CSF NfL 中的个体贡献和相对重要性。

结果

CSF NfL 随年龄增加而升高(r=0.59,p<0.001)。当同时考虑时,CSF NfL 升高与总 WMH 体积增加相关(p<0.001),但与灰质或白质体积无关(p>0.05)。在预测 CSF NfL 时,年龄和 WMH 体积始终比 AD 标志物更重要(即 R 值更高)。

结论

CSF NfL 是衰老和白质完整性的非特异性标志物,对 AD 的特异性标志物敏感性有限。CSF NfL 可能反映与脑血管疾病相关的过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e53/9112943/2f870d734ffd/nihms-1798477-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e53/9112943/acdd81ce6a8d/nihms-1798477-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e53/9112943/b81937d512e4/nihms-1798477-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e53/9112943/2f870d734ffd/nihms-1798477-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e53/9112943/acdd81ce6a8d/nihms-1798477-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e53/9112943/b81937d512e4/nihms-1798477-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e53/9112943/2f870d734ffd/nihms-1798477-f0003.jpg

相似文献

1
Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage.脑脊液神经丝轻链是衰老和白质损伤的标志物。
Neurobiol Dis. 2022 May;166:105662. doi: 10.1016/j.nbd.2022.105662. Epub 2022 Feb 12.
2
Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers.比较 CSF 神经丝轻链、神经颗粒素和 tau 与 MRI 标志物。
Alzheimers Dement. 2021 May;17(5):801-812. doi: 10.1002/alz.12239. Epub 2021 Mar 4.
3
Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.脑脊液神经丝轻链浓度与阿尔茨海默病进展的关联
JAMA Neurol. 2016 Jan;73(1):60-7. doi: 10.1001/jamaneurol.2015.3037.
4
Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.脑脊液中的神经丝蛋白:白质变化的标志物。
J Neurosci Res. 2001 Nov 1;66(3):510-6. doi: 10.1002/jnr.1242.
5
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.血浆神经丝轻链与阿尔茨海默病影像学生物标志物的阶段特异性关联。
Brain. 2020 Dec 1;143(12):3793-3804. doi: 10.1093/brain/awaa342.
6
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.脑脊髓液神经丝轻链蛋白水平与痴呆、运动神经元病和运动障碍患者认知的相关性。
JAMA Neurol. 2019 Mar 1;76(3):318-325. doi: 10.1001/jamaneurol.2018.3746.
7
Associations of Neurodegeneration Biomarkers in Cerebrospinal Fluid with Markers of Alzheimer's Disease and Vascular Pathology.脑脊液神经退行性变生物标志物与阿尔茨海默病和血管病理学标志物的相关性。
J Alzheimers Dis. 2023;92(3):887-898. doi: 10.3233/JAD-221015.
8
Neurofilament relates to white matter microstructure in older adults.神经丝与老年人的白质微观结构有关。
Neurobiol Aging. 2018 Oct;70:233-241. doi: 10.1016/j.neurobiolaging.2018.06.023. Epub 2018 Jun 28.
9
White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.临床前阿尔茨海默病的脑白质高信号与脑脊液阿尔茨海默病生物标志物。
Neurology. 2020 Mar 3;94(9):e950-e960. doi: 10.1212/WNL.0000000000008864. Epub 2019 Dec 30.
10
Significance of CSF NfL and tau in ALS.CSF NfL 和 tau 在 ALS 中的意义。
J Neurol. 2018 Nov;265(11):2633-2645. doi: 10.1007/s00415-018-9043-0. Epub 2018 Sep 5.

引用本文的文献

1
A study on structural imaging changes and serum neurofilament light chain (NfL) levels in individuals with white matter hyperintensities, combining imaging techniques with biomarker analysis.一项关于白质高信号个体的结构成像变化和血清神经丝轻链(NfL)水平的研究,将成像技术与生物标志物分析相结合。
IBRO Neurosci Rep. 2025 May 21;18:794-802. doi: 10.1016/j.ibneur.2025.05.008. eCollection 2025 Jun.
2
Neurofilament Light Chain and Multiple Sclerosis: Building a Neurofoundational Model of Biomarkers and Diagnosis.神经丝轻链与多发性硬化症:构建生物标志物与诊断的神经基础模型
Neurol Int. 2025 Apr 11;17(4):56. doi: 10.3390/neurolint17040056.
3

本文引用的文献

1
Cerebrospinal fluid biomarkers of Alzheimer's disease in a cohort of adults with Down syndrome.唐氏综合征成年人群队列中阿尔茨海默病的脑脊液生物标志物
Alzheimers Dement (Amst). 2020 Jul 9;12(1):e12057. doi: 10.1002/dad2.12057. eCollection 2020.
2
Neurofilaments in disease: what do we know?神经丝在疾病中的作用:我们了解多少?
Curr Opin Neurobiol. 2020 Apr;61:105-115. doi: 10.1016/j.conb.2020.02.001. Epub 2020 Mar 6.
3
Role of Neurofilament Light Chain as a Potential Biomarker for Alzheimer's Disease: A Correlative Meta-Analysis.
Risk factors and clinical significance of neurodegenerative co-pathologies in symptomatic cerebral small vessel disease.
有症状的脑小血管病中神经退行性共病的危险因素及临床意义。
J Neurol. 2025 Apr 18;272(5):349. doi: 10.1007/s00415-025-13087-z.
4
Neuronal and glial dysfunction, white matter hyperintensities and cognition in ageing and Alzheimer's disease.衰老和阿尔茨海默病中的神经元和神经胶质功能障碍、白质高信号与认知
Brain Commun. 2025 Feb 14;7(1):fcaf068. doi: 10.1093/braincomms/fcaf068. eCollection 2025.
5
Associations of Cerebrospinal Fluid Orexin-A, Alzheimer Disease Biomarkers, and Cognitive Performance.脑脊液中食欲素-A、阿尔茨海默病生物标志物与认知表现的关联
Ann Clin Transl Neurol. 2025 Apr;12(4):780-791. doi: 10.1002/acn3.70009. Epub 2025 Feb 17.
6
From Cell Architecture to Mitochondrial Signaling: Role of Intermediate Filaments in Health, Aging, and Disease.从细胞结构到线粒体信号传导:中间丝在健康、衰老和疾病中的作用
Int J Mol Sci. 2025 Jan 27;26(3):1100. doi: 10.3390/ijms26031100.
7
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies.针对脑部疾病中细胞因子介导的炎症:开发新的治疗策略。
Pharmaceuticals (Basel). 2025 Jan 15;18(1):104. doi: 10.3390/ph18010104.
8
Potential biomarkers for cerebral small vessel disease with cognitive impairment: a systematic review and meta-analysis.伴有认知障碍的脑小血管病的潜在生物标志物:一项系统评价和荟萃分析
Front Aging Neurosci. 2025 Jan 7;16:1475571. doi: 10.3389/fnagi.2024.1475571. eCollection 2024.
9
Safety, Tolerability and Pharmacokinetic-Pharmacodynamic Relationship of NX210c Peptide in Healthy Elderly Volunteers: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study.NX210c肽在健康老年志愿者中的安全性、耐受性及药代动力学-药效学关系:随机、安慰剂对照、双盲、多次递增剂量研究
Neurol Ther. 2025 Feb;14(1):357-377. doi: 10.1007/s40120-024-00691-w. Epub 2024 Dec 21.
10
Benchmarking of a multi-biomarker low-volume panel for Alzheimer's disease and related dementia research.用于阿尔茨海默病及相关痴呆症研究的多生物标志物低样本量检测板的基准测试。
Alzheimers Dement. 2025 Feb;21(2):e14413. doi: 10.1002/alz.14413. Epub 2024 Nov 22.
神经丝轻链作为阿尔茨海默病潜在生物标志物的作用:一项相关性荟萃分析。
Front Aging Neurosci. 2019 Sep 13;11:254. doi: 10.3389/fnagi.2019.00254. eCollection 2019.
4
Serum NfL (Neurofilament Light Chain) Levels and Incident Stroke in Adults With Diabetes Mellitus.血清 NfL(神经丝轻链)水平与糖尿病成人中风事件。
Stroke. 2019 Jul;50(7):1669-1675. doi: 10.1161/STROKEAHA.119.024941. Epub 2019 May 29.
5
Neurofilament light chain as a biomarker in neurological disorders.神经丝轻链作为神经紊乱的生物标志物。
J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):870-881. doi: 10.1136/jnnp-2018-320106. Epub 2019 Apr 9.
6
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response.血液神经丝轻链作为 MS 疾病活动和治疗反应的生物标志物。
Neurology. 2019 Mar 5;92(10):e1007-e1015. doi: 10.1212/WNL.0000000000007032. Epub 2019 Feb 8.
7
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease.血清神经丝动态预测无症状阿尔茨海默病的神经退行性变和临床进展。
Nat Med. 2019 Feb;25(2):277-283. doi: 10.1038/s41591-018-0304-3. Epub 2019 Jan 21.
8
Neurofilaments as biomarkers in neurological disorders.神经丝作为神经紊乱的生物标志物。
Nat Rev Neurol. 2018 Oct;14(10):577-589. doi: 10.1038/s41582-018-0058-z.
9
Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies.利用 Centiloid 量表进行 PiB PET 研究的横断和纵向分析。
Neuroimage Clin. 2018 Apr 25;19:406-416. doi: 10.1016/j.nicl.2018.04.022. eCollection 2018.
10
Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden.血清神经丝轻链水平与小血管疾病负担相关。
J Stroke. 2018 May;20(2):228-238. doi: 10.5853/jos.2017.02565. Epub 2018 May 31.